跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42,784 条关于
“rare refractory epilepsies”
全部
42,784
临床试验
33,740
药物
140
机构
336
资讯
8,568
上个月
Servier Builds Rare Neurology Pipeline from the Ground Up Under New R&D Leadership
9个月前
Lundbeck's Bexicaserin Shows Sustained Seizure Reduction in Rare Childhood Epilepsies After Two Years of Treatment
6个月前
Angelini Pharma Partners with Quiver Bioscience in $120M Deal to Advance AI-Driven Therapies for Rare Genetic Epilepsies
去年
Ananda Developments' Cannabinoid Medicines to be Used in NHS Epilepsy Trials
去年
Ananda Developments' Cannabinoid Medicines to Undergo Phase III Trials for Refractory Epilepsy
5个月前
Jazz Pharmaceuticals Presents New Epidiolex Behavioral Data at AAN 2026, Demonstrating Impact Beyond Seizure Control
2年前
Bright Minds Biosciences Initiates Phase 2 Trial of BMB-101 for Drug-Resistant Epilepsies
去年
Antisense Oligonucleotide Therapies Show Promise in Treating Genetic Epilepsies
去年
NHS to Launch Clinical Trials of Cannabis-Based Medicines for Refractory Epilepsy in 2025
去年
Lundbeck to Acquire Longboard Pharmaceuticals for $2.6 Billion, Bolstering Epilepsy Pipeline
第 1 页，共 857 页
上一页
下一页
